July 25, 2016 4:14 PM ET


Company Overview of Immune Design Corp.

Key Executives for Immune Design Corp.

NameBoard RelationshipsTitleAge
Carlos V. Paya M.D., Ph.D.13 RelationshipsChief Executive Officer, President and Director57
Stephen R. Brady J.D., LLMNo RelationshipsPrincipal Financial Officer, Principal Accounting Officer and Executive Vice President of Strategy & Finance46
Adam R. Craig M.D., Ph.D., M.B.A.No RelationshipsInterim Chief Medical Officer50
Frank J. Hsu M.D.No RelationshipsHead of Oncology and Vice President--
Christopher Whitmore CPANo RelationshipsVice President of Finance & Administration--

Immune Design Corp. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Edward Etienne Penhoet Ph.D. 92 RelationshipsAlta Partners LP75
Carlos V. Paya M.D., Ph.D. 13 RelationshipsImmune Design Corp.57
Rafi Ahmed Ph.D. 28 RelationshipsMetaclipse Therapeutics Corporation--
David Baltimore Ph.D. 63 RelationshipsAriad Pharmaceuticals Inc.78
William R. Ringo Jr. 117 RelationshipsPearl Street Venture Funds71
View All Board Members

Immune Design Corp. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CFA, BA, MA, MBAFranklin M. Berger106 Relationships3 Executives
Compensation Committee Jr.William R. Ringo117 Relationships3 Executives
Nominating Committee Ph.D.David Baltimore63 Relationships3 Executives
Corporate Governance Committee Ph.D.David Baltimore63 Relationships3 Executives
Advisory Board Ph.D.Rafi Ahmed28 Relationships7 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$530.5K
Total Value of Options
Compensation as of Fiscal Year
Immune Design Corp. CEO Compensation
Industry Average


Cleveland BioLabs, Inc. Announces Executive Changes
July 22, 2016 8:22 PM ET
TetraLogic Pharmaceuticals Corporation Announces Resignation of Douglas Reed as M. D, Effective July 21, 2016
July 22, 2016 8:18 PM ET
Immunicum AB Appoints Peter Suenaert as Chief Medical Officer
July 22, 2016 10:20 AM ET
ContraFect Corporation Appoints Steven C. Gilman as President and Chief Executive Officer
July 21, 2016 9:32 PM ET
William R. Ringo Intends to Resign from Mirati Therapeutics, Inc.'s Board of Directors
July 21, 2016 8:03 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Immune Design Corp., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.